About this source
- Kind
- Research
- Design
- Meta-analysis, RCT, Systematic review
- Population
- Adult sepsis, severe sepsis and septic shock patients, 11 pooled randomised controlled trials, all China-based
- Sample size
- 1,927 (967 thymosin alpha-1 / 960 control)
- Primary or secondary
- secondary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 13 August 2026
Limitations
All 11 trials China-based; small individual trials; excluded combination-therapy trials; inconsistent sepsis diagnostic criteria across publication years; detected publication bias; headline pooled result loses statistical significance when restricted to high-quality or multi-centre studies alone.
Cited in
Sepsis 28-day mortality
Thymosin Alpha-1 · Research finding
ModerateNo sepsis adverse-event synthesis
Thymosin Alpha-1 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.